Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference
May 25 2022 - 9:00AM
Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer
of innovative cell-based technologies and therapeutics, announced
today that David Jin, M.D., Ph.D., President and Chief Executive
Officer, and Luisa Ingargiola, Chief Financial Officer, of Avalon
GloboCare, will be presenting at the Jefferies 2022 Healthcare
Conference which is being held on June 8–10, 2022 in New York City.
Management is scheduled to present on Friday,
June 10, 2022, at 12:45 PM ET. Management will also be available
for one-on-one meetings with investors during the conference.
About Avalon GloboCare Corp.Avalon
GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage, vertically
integrated, leading CellTech bio-developer dedicated to advancing
and empowering innovative, transformative immune effector cell
therapy, exosome technology, as well as COVID-19 related
diagnostics and therapeutics. Avalon also provides strategic
advisory and outsourcing services to facilitate and enhance its
clients' growth and development, as well as competitiveness in
healthcare and CellTech industry markets. Through its subsidiary
structure with unique integration of verticals from innovative
R&D to automated bioproduction and accelerated clinical
development, Avalon is establishing a leading role in the fields of
cellular immunotherapy (including CAR-T/NK), exosome technology
(ACTEX™), and regenerative therapeutics. For more information about
Avalon GloboCare, please visit www.avalon-globocare.com.
For the latest updates on Avalon GloboCare's
developments, please follow our twitter at @avalongc_avco
Forward-Looking StatementsCertain
statements contained in this press release may constitute
"forward-looking statements." Forward-looking statements provide
current expectations of future events based on certain assumptions
and include any statement that does not directly relate to any
historical or current fact. Actual results may differ materially
from those indicated by such forward-looking statements as a result
of various important factors as disclosed in our filings with the
Securities and Exchange Commission located at their website
(http://www.sec.gov). In addition to these factors, actual future
performance, outcomes, and results may differ materially because of
more general factors including (without limitation) general
industry and market conditions and growth rates, economic
conditions, and governmental and public policy changes. The
forward-looking statements included in this press release represent
the Company's views as of the date of this press release and these
views could change. However, while the Company may elect to update
these forward-looking statements at some point in the future, the
Company specifically disclaims any obligation to do so. These
forward-looking statements should not be relied upon as
representing the Company's views as of any date subsequent to the
date of the press release.
Contact Information: Avalon
GloboCare Corp.4400 Route 9, Suite 3100Freehold, NJ
07728PR@Avalon-GloboCare.com
Investor Relations:Crescendo Communications,
LLCTel: (212) 671-1020 Ext. 304avco@crescendo-ir.com
Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart
From Sep 2023 to Sep 2024